European Medicines Agency Investigation On January 17, 2025, the European Medicines Agency (EMA) Pharmacovigilance Risk Assessment Committee launched a review of semaglutide medications such as Ozempic and Wegovy due to the increased risk of developing NAION
Youll focus on muscular endurance, strength, and power to kickstart your metabolism and caloric burn
Five doses of cagrilintide were examined (0.3, 0.6, 1.2, 2.4, or 4.5 mg) compared to a single dose of liraglutide (3.0 mg) or volume-matched placebo for 6 placebo groups
Research shows that as few as two nights of poor sleep can measurably change gut microbiome activity in ways that increase gas production
L-carnitine is particularly beneficial for tissues that use fatty acids as fuel, such as skeletal and cardiac muscle